Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Journal of Scleroderma and Related Disorders
|
June 8, 2023
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review
Fabio Cacciapaglia, Stefano Stano, Marco Fornaro, et al.
Clinical Rheumatology
|
January 11, 2019
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis
Vincenzo Venerito, Giuseppe Lopalco, Fabio Cacciapaglia, et al.
European Journal of Clinical Investigation
|
July 30, 2020
Predictors of long-term clinical remission in rheumatoid arthritis
Marco Fornaro, Fabio Cacciapaglia, Giuseppe Lopalco, et al.
Journal of Personalized Medicine
|
March 25, 2022
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis
Fabio Cacciapaglia, Vincenzo Venerito, Stefano Stano, et al.
Rheumatology (Oxford, England)
|
November 22, 2023
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis
Florenzo Iannone, Giuseppe Lopalco, Fabio Cacciapaglia, et al.
Rheumatology (Oxford, England)
|
October 26, 2019
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis
Florenzo Iannone, Mariangela Nivuori, Marco Fornaro, et al.
European Journal of Clinical Investigation
|
July 13, 2020
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis
Fabio Cacciapaglia, Marco Fornaro, Vincenzo Venerito, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 20, 2021
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents
Vincenzo Venerito, Orazio Angelini, Marco Fornaro, et al.
Reumatismo
|
April 7, 2025
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies
Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, et al.
Clinical and Experimental Rheumatology
|
September 8, 2021
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study
Simone Perniola, Rita Bizzoca, Marco Fornaro, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Journal of Scleroderma and Related Disorders
|
June 8, 2023
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review
Fabio Cacciapaglia, Stefano Stano, Marco Fornaro, et al.
Clinical Rheumatology
|
January 11, 2019
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis
Vincenzo Venerito, Giuseppe Lopalco, Fabio Cacciapaglia, et al.
European Journal of Clinical Investigation
|
July 30, 2020
Predictors of long-term clinical remission in rheumatoid arthritis
Marco Fornaro, Fabio Cacciapaglia, Giuseppe Lopalco, et al.
Journal of Personalized Medicine
|
March 25, 2022
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis
Fabio Cacciapaglia, Vincenzo Venerito, Stefano Stano, et al.
Rheumatology (Oxford, England)
|
November 22, 2023
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis
Florenzo Iannone, Giuseppe Lopalco, Fabio Cacciapaglia, et al.
Rheumatology (Oxford, England)
|
October 26, 2019
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis
Florenzo Iannone, Mariangela Nivuori, Marco Fornaro, et al.
European Journal of Clinical Investigation
|
July 13, 2020
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis
Fabio Cacciapaglia, Marco Fornaro, Vincenzo Venerito, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
September 20, 2021
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents
Vincenzo Venerito, Orazio Angelini, Marco Fornaro, et al.
Reumatismo
|
April 7, 2025
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies
Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, et al.
Clinical and Experimental Rheumatology
|
September 8, 2021
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study
Simone Perniola, Rita Bizzoca, Marco Fornaro, et al.
Page
of 8